Adrenalone
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Adrenalone
- DrugBank Accession Number
- DB13394
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 181.191
Monoisotopic: 181.073893218 - Chemical Formula
- C9H11NO3
- Synonyms
- 1-(3,4-DIHYDROXYPHENYL)-2-(METHYLAMINO)ETHANONE
- 3',4'-dihydroxy-2-(methylamino)acetophenone
- 4-Methylaminoacetocatechol
- Adrenalona
- Adrenalone
- Adrenone
- ETHANONE, 1-(3,4-DIHYDROXYPHENYL)-2-(METHYLAMINO)-
- External IDs
- NSC-243611
- U 2134
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareChloroprocaine The risk or severity of adverse effects can be increased when Adrenalone is combined with Chloroprocaine. Levothyroxine Levothyroxine may increase the vasoconstricting activities of Adrenalone. Lidocaine The risk or severity of hypertension can be increased when Adrenalone is combined with Lidocaine. Liothyronine Liothyronine may increase the vasoconstricting activities of Adrenalone. Liotrix Liotrix may increase the vasoconstricting activities of Adrenalone. - Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Product Ingredients
Ingredient UNII CAS InChI Key Adrenalone hydrochloride NN82YWE2IC 62-13-5 CSRRBDMYOUQTCO-UHFFFAOYSA-N
Categories
- ATC Codes
- A01AD06 — Adrenalone
- A01AD — Other agents for local oral treatment
- A01A — STOMATOLOGICAL PREPARATIONS
- A01 — STOMATOLOGICAL PREPARATIONS
- A — ALIMENTARY TRACT AND METABOLISM
- Drug Categories
- Alcohols
- Alimentary Tract and Metabolism
- Amines
- Amino Alcohols
- Benzene Derivatives
- Biogenic Amines
- Biogenic Monoamines
- Blood and Blood Forming Organs
- Cardiovascular Agents
- Catecholamines
- Catechols
- Coagulants
- Ethanolamines
- Hematologic Agents
- Hemostatics
- Local Hemostatics
- Phenols
- Stomatological Preparations
- Vasoconstrictor Agents
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as alkyl-phenylketones. These are aromatic compounds containing a ketone substituted by one alkyl group, and a phenyl group.
- Kingdom
- Organic compounds
- Super Class
- Organic oxygen compounds
- Class
- Organooxygen compounds
- Sub Class
- Carbonyl compounds
- Direct Parent
- Alkyl-phenylketones
- Alternative Parents
- Catechols / Benzoyl derivatives / Aryl alkyl ketones / 1-hydroxy-4-unsubstituted benzenoids / 1-hydroxy-2-unsubstituted benzenoids / Alpha-amino ketones / Dialkylamines / Organopnictogen compounds / Organic oxides / Hydrocarbon derivatives
- Substituents
- 1-hydroxy-2-unsubstituted benzenoid / 1-hydroxy-4-unsubstituted benzenoid / Alkyl-phenylketone / Alpha-aminoketone / Amine / Aromatic homomonocyclic compound / Aryl alkyl ketone / Benzenoid / Benzoyl / Catechol
- Molecular Framework
- Aromatic homomonocyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- EGU41QL329
- CAS number
- 99-45-6
- InChI Key
- PZMVOUYYNKPMSI-UHFFFAOYSA-N
- InChI
- InChI=1S/C9H11NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,10-12H,5H2,1H3
- IUPAC Name
- 1-(3,4-dihydroxyphenyl)-2-(methylamino)ethan-1-one
- SMILES
- CNCC(=O)C1=CC(O)=C(O)C=C1
References
- General References
- Not Available
- External Links
- ChemSpider
- 7158
- BindingDB
- 94970
- 17073
- ChEBI
- 134821
- ChEMBL
- CHEMBL2103996
- ZINC
- ZINC000034781660
- Wikipedia
- Adrenalone
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 8.68 mg/mL ALOGPS logP -0.55 ALOGPS logP -0.18 Chemaxon logS -1.3 ALOGPS pKa (Strongest Acidic) 7.5 Chemaxon pKa (Strongest Basic) 8.24 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 3 Chemaxon Polar Surface Area 69.56 Å2 Chemaxon Rotatable Bond Count 3 Chemaxon Refractivity 48.56 m3·mol-1 Chemaxon Polarizability 18.32 Å3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-008i-1900000000-fbf0b5d6eb3ae1bacebb Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-001i-0900000000-20221527e0daca6696c1 Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-00di-3900000000-28270ce6c0547a665367 Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-0080-0900000000-4bc32829b18dfbf920aa Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-00dl-8900000000-32d1cd6a0b082e69ac52 Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-00du-7900000000-42329acef725fee83196 Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 146.5445199 predictedDarkChem Lite v0.1.0 [M-H]- 136.97942 predictedDeepCCS 1.0 (2019) [M+H]+ 147.7123199 predictedDarkChem Lite v0.1.0 [M+H]+ 139.90488 predictedDeepCCS 1.0 (2019) [M+Na]+ 146.9654199 predictedDarkChem Lite v0.1.0 [M+Na]+ 149.04987 predictedDeepCCS 1.0 (2019)
Drug created at June 23, 2017 20:41 / Updated at November 07, 2024 23:54